Loading patent…
AssigneesPhylogica Limited, The McComb Foundation, Inc.
InventorsMark Fear, Paul Watt, Richard Hopkins, Nadia Milech
Estimating the term…
The present invention provides a topical composition comprising (i) an amount of an AP-1 signaling inhibitor sufficient to reduce, delay or prevent apoptosis and/or necrosis induced by dermal wounding and/or to induce and/or enhance proliferation of a cell; and (ii) a suitable carrier or excipient e.g., a topical carrier or excipient or other carrier or excipient for dermal application. For example, the AP-1 signaling inhibitor is a peptide analog comprising the sequence set forth in SEQ ID NO: 104. The present invention also provides a method of treating a dermal wound comprising topically administering said topical composition to a subject suffering from a dermal wound.
A topical composition comprising (i) an amount of a peptide or peptide analog that is an AP-1 signaling inhibitor sufficient to reduce, delay or prevent apoptosis and/or necrosis induced by dermal wounding and/or to induce and/or enhance proliferation of a cell;
2-8. (canceled)
(canceled)
13-14. (canceled)
19-20. (canceled)
26-27. (canceled)
(canceled)
(canceled)
(canceled)
36-41. (canceled)
43-45. (canceled)
Dependencies are inferred from the claim text.